title: [Case report; a case of acute kidney injury due to intravenous zoledronic acid hydrate, improved with bortezomib plus dexamethazone therapy in a patient with multiple myeloma].
authors.affiliation: Division of Nephrology, Department of Medicine, Kurume University School of Medicine, Japan.
authors.forename: Kiyomi
authors.initials: K
authors.lastname: Koike
authors.forename: Satoshi
authors.initials: S
authors.lastname: Morishige
authors.forename: Kei
authors.initials: K
authors.lastname: Fukami
authors.forename: Kensei
authors.initials: K
authors.lastname: Taguchi
authors.forename: Kazuaki
authors.initials: K
authors.lastname: Yakushiji
authors.forename: Takashi
authors.initials: T
authors.lastname: Okamura
authors.forename: Seiya
authors.initials: S
authors.lastname: Okuda
mesh_terms: D058186:Acute Kidney Injury / Q000139:chemically induced*; D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage*; D001897:Boronic Acids / Q000008:administration & dosage*; D000069286:Bortezomib; D003907:Dexamethasone / Q000008:administration & dosage*; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000009:adverse effects*; D007275:Injections, Intravenous; D008297:Male; D009101:Multiple Myeloma / Q000188:drug therapy*; D011719:Pyrazines / Q000008:administration & dosage*; D000077211:Zoledronic Acid
chemical_list: D000970:Antineoplastic Agents; D018931:Antineoplastic Agents, Hormonal; D001897:Boronic Acids; D004164:Diphosphonates; D007093:Imidazoles; D011719:Pyrazines; D000069286:Bortezomib; D000077211:Zoledronic Acid; D003907:Dexamethasone